We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Phase 2 single-arm, baseline-controlled trial evaluating QTORINβ’ 3.9% rapamycin anhydrous gel (QTORINβ’ rapamycin) for the treatment of cutaneous venous malformations (cutaneous VMs) to enroll...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.5 | 21.2765957447 | 11.75 | 15.67 | 11.28 | 67956 | 13.98902789 | CS |
4 | 1.85 | 14.9193548387 | 12.4 | 15.67 | 11.1 | 44105 | 13.1562396 | CS |
12 | 1.85 | 14.9193548387 | 12.4 | 15.67 | 11.1 | 44105 | 13.1562396 | CS |
26 | 1.85 | 14.9193548387 | 12.4 | 15.67 | 11.1 | 44105 | 13.1562396 | CS |
52 | 1.85 | 14.9193548387 | 12.4 | 15.67 | 11.1 | 44105 | 13.1562396 | CS |
156 | 1.85 | 14.9193548387 | 12.4 | 15.67 | 11.1 | 44105 | 13.1562396 | CS |
260 | 1.85 | 14.9193548387 | 12.4 | 15.67 | 11.1 | 44105 | 13.1562396 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions